885267-00-5 Usage
Description
N-Bromoacetylazetidine is a brominated acetylazetidine, a type of organic compound characterized by a four-membered ring containing a nitrogen atom and an acetyl group. With the molecular formula C4H6BrNO, this colorless liquid possesses a pungent odor and is highly reactive due to the bromine atom. Its unique properties and reactivity make it a valuable compound in various chemical reactions and hold potential in medicinal chemistry and drug development.
Uses
Used in Organic Synthesis:
N-Bromoacetylazetidine is utilized as a reagent for the bromination of organic molecules, playing a crucial role in enhancing the properties and reactivity of other compounds in organic synthesis processes.
Used in Pharmaceutical Research:
In the pharmaceutical industry, N-Bromoacetylazetidine serves as an important reagent for the development of new drugs and medicinal compounds. Its unique reactivity and properties contribute to the advancement of pharmaceutical research and drug discovery.
Used in Medicinal Chemistry:
N-Bromoacetylazetidine's potential implications in medicinal chemistry stem from its ability to participate in various chemical reactions that can lead to the creation of novel and effective pharmaceutical agents.
Check Digit Verification of cas no
The CAS Registry Mumber 885267-00-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,2,6 and 7 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 885267-00:
(8*8)+(7*8)+(6*5)+(5*2)+(4*6)+(3*7)+(2*0)+(1*0)=205
205 % 10 = 5
So 885267-00-5 is a valid CAS Registry Number.
885267-00-5Relevant articles and documents
SUBSTITUTED 1H-IMIDAZO[4,5-B]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS
-
Page/Page column 104, (2018/04/23)
Substituted 1 H-imidazo[4,5-b]pyridin-2(3H)-ones as NR2B receptor ligands. Such compounds may be used in NR2B receptor modulation and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by NR2B receptor activity.
